DC Investments Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,186
Closed -$851K 195
2020
Q2
$851K Buy
5,186
+66
+1% +$10.1K 0.31% 37
2020
Q1
$710K Buy
5,120
+432
+9% +$59.4K 0.58% 26
2019
Q4
$616K Buy
4,688
+78
+2% +$9.04K 0.47% 43
2019
Q3
$516K Sell
4,610
-440
-9% -$49K 0.3% 121
2019
Q2
$559K Buy
5,050
+1,816
+56% +$214K 0.31% 118
2019
Q1
$420K Hold
3,234
0.27% 175
2018
Q4
$374K Buy
+3,234
New +$361K 0.3% 167
2018
Q2
Sell
-3,709
Closed -$287K 349
2018
Q1
$287K Sell
3,709
-15,104
-80% -$1.22M 0.19% 193
2017
Q4
$1.59M Buy
+18,813
New +$1.6M 0.66% 12

Other funds holding LLY

DC Investments Management's LLY Position: Q3 2020 in Review

DC Investments Management sold out of Eli Lilly (LLY) in Q3 2020, closing a stake of 5,186 shares — an estimated $851K sold.

DC Investments Management first reported a position in LLY in Q4 2017 and held it in 9 quarters. The position peaked at $1.59M in Q4 2017. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • DC Investments Management reported no remaining Eli Lilly position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 5,186 Eli Lilly shares in Q3 2020, an estimated $851K.
  • DC Investments Management first reported a position in Eli Lilly in Q4 2017 and held it in 9 quarters.
  • DC Investments Management's Eli Lilly position peaked at $1.59M in Q4 2017.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.